Express Pharma

DCGI approves “Conditional Market Authorisation” of Covaxin and Covishield

The approval pathways through this route are fast-tracked with certain conditions to enhance the access to certain pharmaceuticals for meeting the emerging needs of drugs or vaccines

0 315